A novel role of thrombopoietin as a physiological modulator of coronary flow

被引:12
作者
Ramella, Roberta [1 ]
Gallo, Maria Pia [1 ]
Spatola, Tiziana [2 ]
Lupia, Enrico [2 ]
Alloatti, Giuseppe [1 ,3 ]
机构
[1] Univ Turin, Dept Anim & Human Biol, I-10123 Turin, Italy
[2] Univ Turin, Dept Clin Pathophysiol, I-10123 Turin, Italy
[3] INRC, Bologna, Italy
关键词
Thrombopoietin; Coronary flow; Nitric oxide; Nitric oxide synthase; Endothelial cell; NITRIC-OXIDE; ACTIVATION; HEART;
D O I
10.1016/j.regpep.2010.12.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thrombopoietin (TPO) is known for its ability to stimulate platelet production. However, little is currently known whether TPO plays a physiological function in the heart. The potential vasodilatory role of TPO was tested on the isolated rat heart. The expression of TPO receptor (c-mpl) and the TPO-dependent eNOS phosphorylation (P-Ser1179) were studied on Cardiac-derived normal Human Micro Vascular Endothelial Cells (HMVEC-C) by Western blot analysis. While TPO (10-200 pg/mL) did not modify coronary flow (CF) under basal conditions, it reduced the coronary constriction caused by endothelin-1 (ET-1; 10 nM) in a dose-dependent manner. This effect was blocked by both Wortmannin (100 nM) and L-NAME (100 nM); on HMVEC-C, TPO induced eNOS phosphorylation through a Wortmannin sensitive mechanism. Taken together, our data suggest a potential role of TPO as a physiological regulator of CF. By acting on specific receptors present on endothelial cells, TPO may induce PI3K/Akt-dependent eNOS phosphorylation and NO release. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 25 条
[1]  
Alloatti G, 1998, J PHARMACOL EXP THER, V284, P561
[2]   Human thrombopoietin reduces myocardial infarct size, apoptosis, and stunning following ischaemia/reperfusion in rats [J].
Baker, John E. ;
Su, Jidong ;
Hsu, Anna ;
Shi, Yang ;
Zhao, Ming ;
Strande, Jennifer L. ;
Fu, Xiangping ;
Xu, Hao ;
Eis, Annie ;
Komorowski, Richard ;
Jensens, Eric S. ;
Tweddell, James S. ;
Rafiee, Parvaneh ;
Gross, Garrett J. .
CARDIOVASCULAR RESEARCH, 2008, 77 (01) :44-53
[3]   Regulation of polymorphonuclear cell activation by thrombopoietin [J].
Brizzi, MF ;
Battaglia, E ;
Rosso, A ;
Strippoli, P ;
Montrucchio, G ;
Camussi, G ;
Pegoraro, L .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1576-1584
[4]  
Brizzi MF, 1999, CIRC RES, V84, P785
[5]  
BRUNNER F, 2006, PHARMACOL THERAPEUT, V26, P364
[6]   Thrombopoietin levels in patients with primary and reactive thrombocytosis [J].
Cerutti, A ;
Custodi, P ;
Duranti, M ;
Noris, P ;
Balduini, CL .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 99 (02) :281-284
[7]   Interactive relations between nitric oxide (NO) and carbon monoxide (CO): Heme oxygenase-1/CO pathway is a key modulator in NO-Mediated antiapoptosis and anti-inflammation [J].
Chung, Hun-Taeg ;
Choi, Byung-Min ;
Kwon, Young-Guen ;
Kim, Young-Myeong .
NITRIC OXIDE, PT G: OXIDATIVE AND NITROSATIVE STRESS IN REDOX REGULATION OF CELL SIGNALING, 2008, 441 :329-338
[8]  
COLARIZI P, 2001, J LAB CLIN MED, V137, P64
[9]   Signaling pathways in ischemic preconditioning [J].
Downey, James M. ;
Davis, Amanda M. ;
Cohen, Michael V. .
HEART FAILURE REVIEWS, 2007, 12 (3-4) :181-188
[10]   Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction [J].
Emmons, RVB ;
Reid, DM ;
Cohen, RL ;
Meng, G ;
Young, NS ;
Dunbar, CE ;
Shulman, NR .
BLOOD, 1996, 87 (10) :4068-4071